BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Alexion Pharmaceuticals Inc. (ALXN) To Present At The Smith Barney Citigroup 2005 Small And Mid-Cap Conference


10/19/2005 5:12:41 PM

CHESHIRE, Conn., Feb. 10 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the Smith Barney Citigroup 2005 Small and Mid-Cap Conference in Las Vegas at 10:45 a.m. local time (1:45 p.m. eastern) on Thursday, February 17, 2005.

An audio webcast of Dr. Bell's remarks will be available live. You can access the webcast at: http://www.alexionpharm.com/. An archived version of the remarks will also be available through the Company's web site for a limited time following the conference.

Contacts: Alexion Pharmaceuticals, Inc. Leonard Bell, M.D. Chief Executive Officer (203) 272-2596 Noonan/Russo Robert Stanislaro (Media) (212) 845-4268 Rx Communications Rhonda Chiger (Investor) (917) 322-2569

Alexion Pharmaceuticals, Inc.

CONTACT: Leonard Bell, M.D., Chief Executive Officer of AlexionPharmaceuticals, +1-203-272-2596, or Media, Robert Stanislaro of Noonan/Russo,+1-212-845-4268, or Investor, Rhonda Chiger of Rx Communications,+1-917-322-2569, both for Alexion Pharmaceuticals



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES